UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

PLoS medicine, 2016-12, Vol.13 (12), p.e1002193-e1002193

2016

Volltextzugriff (PDF)

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity

Cell reports (Cambridge), 2018-11, Vol.25 (6), p.1446-1457

2018

Volltextzugriff (PDF)

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific reports, 2019-10, Vol.9 (1), p.14934-10, Article 14934

2019

Volltextzugriff (PDF)

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers

Genome medicine, 2021-04, Vol.13 (1), p.70-14, Article 70

2021

Volltextzugriff (PDF)

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Clinical epigenetics, 2018-08, Vol.10 (1), p.112-11, Article 112

2018

Volltextzugriff (PDF)

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations

NPJ breast cancer, 2021-05, Vol.7 (1), p.60-60, Article 60

2021

Volltextzugriff (PDF)

Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells

BMC cancer, 2010-03, Vol.10 (1), p.84-84, Article 84

2010

Volltextzugriff (PDF)

Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis

Breast cancer research : BCR, 2014-12, Vol.16 (6), p.501, Article 501

2014

Volltextzugriff (PDF)

Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells

Molecular cancer research, 2014-08, Vol.12 (8), p.1140-1155

2014

Volltextzugriff (PDF)

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4), p.927-939

2016

Volltextzugriff (PDF)

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (2), p.566-578

2017

Volltextzugriff (PDF)

Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome

Clinical cancer research, 2020-04, Vol.26 (8), p.1977-1984

2020

Volltextzugriff (PDF)

Synergistic Antiproliferative Effects of γ-Tocotrienol and Statin Treatment on Mammary Tumor Cells

Lipids, 2007-12, Vol.42 (12), p.1113-1123

2007

Volltextzugriff (PDF)

Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer

Clinical cancer research, 2017-03, Vol.23 (5), p.1193-1199

2017

Volltextzugriff (PDF)

Endoplasmic reticulum stress mediates γ-tocotrienol-induced apoptosis in mammary tumor cells

Apoptosis (London), 2009-11, Vol.14 (11), p.1366-1377

2009

Volltextzugriff (PDF)

Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer

BMC genomics, 2014-10, Vol.15 (1), p.876-876, Article 876

2014

Volltextzugriff (PDF)

Combined Treatment of γ-Tocotrienol with Statins Induce Mammary Tumor Cell Cycle Arrest in G1

Experimental biology and medicine (Maywood, N.J.), 2009-06, Vol.234 (6), p.639-650

2009

Volltextzugriff (PDF)

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Cancers, 2020-09, Vol.12 (9), p.2551

2020

Volltextzugriff (PDF)

Combined γ-Tocotrienol and Erlotinib/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells

Anticancer research, 2010-02, Vol.30 (2), p.429-437

2010

Volltextzugriff (PDF)

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors

Oncotarget, 2017-03, Vol.8 (13), p.21733-21740

2017

Volltextzugriff (PDF)

Suppression in Mevalonate Synthesis Mediates Antitumor Effects of Combined Statin and γ-Tocotrienol Treatment

Lipids, 2009-10, Vol.44 (10), p.925-934

2009

Volltextzugriff (PDF)

Characterization of DNA variants in the human kinome in breast cancer

Scientific reports, 2015-09, Vol.5 (1), p.14736-14736, Article 14736

2015

Volltextzugriff (PDF)

Tocotrienol combination therapy results in synergistic anticancer response

Frontiers in bioscience, 2011-06, Vol.16 (8), p.3183

2011

Volltextzugriff (PDF)

Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue

Molecular oncology, 2014-05, Vol.8 (3), p.717-727

2014

Volltextzugriff (PDF)

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors

Bioorganic & medicinal chemistry, 2010-11, Vol.18 (22), p.8066-8075

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations

Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells

Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis

Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer

Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome

Synergistic Antiproliferative Effects of γ-Tocotrienol and Statin Treatment on Mammary Tumor Cells

Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer

Endoplasmic reticulum stress mediates γ-tocotrienol-induced apoptosis in mammary tumor cells

Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer

Combined Treatment of γ-Tocotrienol with Statins Induce Mammary Tumor Cell Cycle Arrest in G1

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Combined γ-Tocotrienol and Erlotinib/Gefitinib Treatment Suppresses Stat and Akt Signaling in Murine Mammary Tumor Cells

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors

Suppression in Mevalonate Synthesis Mediates Antitumor Effects of Combined Statin and γ-Tocotrienol Treatment

Characterization of DNA variants in the human kinome in breast cancer

Tocotrienol combination therapy results in synergistic anticancer response

Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors

Suchergebnisse filtern